European Journal of Molecular & Clinical Medicine

Abstract

Background: Chronic Renal Disease is a fast-growing disease worldwide achieving the endemic levels. The use of NSAIDs has been associated with renal function deterioration through variable mechanisms. Present study was aimed at pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease at a tertiary hospital. Material and Methods: Present study was retrospective, case record-based analysis conducted in case records of patients admitted & diagnosed as nonsteroidal anti-inflammatory drugs-(NSAID) induced chronic kidney disease. Results: In present study, 48 case records evaluated. Majority patients were from 51-60 years (37.5 %) & 41-50 years age group (27.08 %), were male (68.75 %) & labourer by occupation (52.08 %). Common co-morbidities noted were hypertension (77.08 %), bone and joint disease (33.33 %), diabetes (31.25 %), cardiovascular disease (29.17 %) & malignancy (4.17 %). Among 48 patients, common CKD stage was Stage 3a (39.58 %) followed by Stage 3b (29.17 %), Stage 2 (22.92 %) & Stage 4 (8.33 %). Treatment receiving were Hemodialysis (54.17 %), Only medicine (22.92 %), Peritoneal dialysis (10.42 %) & Kidney transplantation (12.5 %), Common NSAIDs used was Diclofenac/Aceclofenac (45.83 %), Paracetamol (39.58 %), Ibuprofen (27.08 %), Ketorolac (4.17 %) & Nimesulide (4.17 %). Oral Route of administration was common (77.08 %). Though majority of patients using 1 NSAID (47.92 %) followed by 2 NSAIDs use (35.42 %), ≥3 NSAIDs use (16.67 %). Common purpose of use was headache (60.42 %), generalized pain (45.83 %), joint pain (33.33 %), dental pain (14.58 %), menstrual pain (12.50 %) & renal colic (8.33 %). Conclusion: Non-steroidal anti-inflammatory drug induced nephrotoxicity should be considered as significant adverse effect. Physicians & general practitioners should discourage on the counter use of NSAIDs.